Compare GNK & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNK | TLRY |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 856.0M | 919.2M |
| IPO Year | 2005 | 2018 |
| Metric | GNK | TLRY |
|---|---|---|
| Price | $22.81 | $6.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $19.00 | ★ $103.33 |
| AVG Volume (30 Days) | 606.2K | ★ 2.2M |
| Earning Date | 05-06-2026 | 04-07-2026 |
| Dividend Yield | ★ 4.17% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $342,054,000.00 | N/A |
| Revenue This Year | $21.41 | $7.39 |
| Revenue Next Year | $1.18 | $4.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.20 | $0.36 |
| 52 Week High | $24.81 | $15.70 |
| Indicator | GNK | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 55.33 | 34.92 |
| Support Level | $15.58 | $1.00 |
| Resistance Level | $24.46 | $8.20 |
| Average True Range (ATR) | 0.91 | 0.32 |
| MACD | -0.21 | -0.04 |
| Stochastic Oscillator | 64.84 | 0.16 |
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.